Navigation Links
DOE Labs Take Pride in Award-Winning IBM Blue Gene Series
Date:10/7/2009

national security.

"Blue Gene balances energy efficiencies with a major breakthrough in scalability, which is imperative to attack problems in science and engineering at unprecedented scale and speed," said Pete Beckman, director of Argonne's Leadership Computing Facility, home to the first large Blue Gene/P.

The Blue Gene leverages a high-performance, low-power, system-on-a-chip architecture offering extreme integration that dramatically improves reliability, increases energy efficiency and reduces operating costs.

"The Blue Gene architecture has greatly enhanced the National Nuclear Security Administration's capability for predictive simulation and uncertainty quantification," said Mark Seager, Asst. Dept. Head for Advanced Computing Technology at LLNL.

Much of the software needed to operate Blue Gene comes from the open source community and was developed by laboratories and universities around the world. Argonne was actively involved in fostering that community as well as developing key components of the system software. For example, the Blue Gene leverages Argonne's MPICH, the version of the Message Passing Interface that scientists use to write parallel programs capable of scaling to hundreds of thousands of CPU cores. Computer scientists are also working on extending the capabilities of Blue Gene with advanced math libraries, improved parallel file systems, and even experimental operating systems such as ZeptoOS, which permits users to run Linux on the Blue Gene's compute nodes.

Another critical aspect of the Blue Gene's success was ensuring the platform was adopted by the high-performance computing community. In 2004, Argonne and IBM jointly created the Blue Gene Consortium, an international group of laboratory, university and industrial researchers collaborating to evaluate the technology and platform and provide critical feedback for future Blue Gene designs.

The Medal of
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. MultiVu Video Feed: Easypod(R), Award-Winning Electronic Device
2. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
3. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
4. Perceptum Group Announces New Situational Leadership V Series
5. Agendia Raises US $23 Million in Series E Financing
6. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
7. PharmAbcine Closes USD $6 Million Series A Financing
8. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
9. Alimera Sciences Closes $5 Million in Extended Series C Financing
10. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
11. ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DOE Labs Take Pride in Award-Winning IBM Blue Gene Series 
DOE Labs Take Pride in Award-Winning IBM Blue Gene Series
(Date:11/23/2009)...ABY,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,In...Ph.DasitsPresidentandCEO. ,, Abramsbringsmoreth...Inimex.Heisaco-inventorofthenuclearmedicineimaging...atthey,plcwherehewasManager,BiomedicalResearchWorl...angley,BCandwasPresidentandCEOfrom1996to2006.AnorM...
(Date:11/20/2009)...Latin American countries have an opportunity to ta...searchers from the University of Valencia (UV), wo...tudied the productive fabric of the Spanish biotec... food and plant sectors have more clout than those...as applied to food and plants has been overlooked ...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cell...nnounced today that the Ninth Circuit Court of App...d that CTI should be allowed to pursue all of its ...ck to the District Court for trial. CTI filed a c...d-party reimbursement consultant for CTI,s product...
(Date:11/19/2009)...EATTLE, Nov. 19 Omeros C...ted financial results for the third quarter ended ...tember 30, 2009, Omeros reported a net loss of $3....t loss of $7.4 million, or $2.54 per share, for th...eptember 30, 2009, the Company reported a net loss...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...ug Royalty LP 2 (DRC) announced,today the purchase...rldwide,royalty interest in PEG-INTRON for $92.5M.... 2012 should certain royalty recognition levels be...oved for the treatment of,Hepatitis C and is marke.... Speaking on behalf of DRC, Paul Kirkconnell, Ma...
...Aug. 27 NeurogesX, Inc.,(Nasdaq: NGSX ), a bioph...ain management therapies, announced today that it ...the Biotech Industry Conference on Thursday,Septem...Executive Officer,and Stephen Ghiglieri, Chief Fin...hursday, September 6, 2007 Time: 2:00 p.m. ...
...DA and Committed to Addressing Unmet Needs of ... - - Conference Call Scheduled for 4:3... Inc.,(Nasdaq: IDMI ) announced today that it rec...nd Drug Administration (FDA) after completing the,...nvestigational drug,mifamurtide (L-MTP-PE), former...
Other Biology Technology:Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 2IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 4IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 5IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 6IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 7
(Date:11/22/2009)... WASHINGTON, D.C. November 18, 2009 -- A butterfly...and used for sipping -- but it works more like a p...son University. He hopes to borrow the tricks of t...hat can sample the fluid inside of cells. , Korn...ual Meeting of the American Physical Society,s (AP...
(Date:11/22/2009)...cientists at the Brain Research Centre, a partners...of Medicine and Vancouver Coastal Health Research ...e mechanism by which brain cells die following a s...damage. The results of the study were recently pub...a stroke, many brain cells continue to die even af...
(Date:11/20/2009)... NJIT researchers are at work on many scientific a...oundation has recently provided support that total...he following investigators under the American Reco...archers have been awarded grants for investigation...d professor of physics, will enhance the capabilit...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Southern California Surgical Center 28heart411 com 29 Specializes in Mitral Valve Replacement 52836 1Southern California Surgical Center 28heart411 com 29 Specializes in Mitral Valve Replacement 52836 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 1Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 3Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 1Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 2
... The earliest humans almost certainly walked uprig...en half the speed of modern man, new research sugg...nted to the BA (British Association for the Advanc...uesday proposes that if early humans lacked an Ac...hen their ability to run would have been severely ...
...COKEEK, Md., Sept. 10 Beretta U.S.A. Corp. announ...U.S. Army and U.S. Navy for a,total of 10,576 M9 p...he,purchase orders were issued against a multi-yea...y, which serves as executive purchasing agent of t...rces. "We are always honored to be given the oppo...
...nference Embarks on New Strategic Direction in 21s... and HDD Suppliers Under One Roof, SUNNYVALE, Cal...nd its robust dynamic supply chain, IDEMA today an...he premier storage industry event, to be,held on S...a Clara,Convention Center in Santa Clara, Californ...
Other Biology News:Was ability to run early man's Achilles heel? 2Was ability to run early man's Achilles heel? 3U.S. Army and Navy Purchase Over 10,000 New Beretta M9 Pistols 2IDEMA Reveals Program Highlights for DISKCON USA 2007 2IDEMA Reveals Program Highlights for DISKCON USA 2007 3IDEMA Reveals Program Highlights for DISKCON USA 2007 4
Mouse Anti-beta-lactoglobulin Monoclonal Antibody, Unconjugated, Clone CD-2 from Cosmo Bio Co., Ltd.
...ti-AP-2 α, clone 8G8/5 GenBank Accession Nu...an AP-2alpha/gamma fusion protein corresponding to...s 278-450 of human AP-2γ Formulation: 0.1M T...e before the addition of glycerol to 30% Quality A...
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Costar 6 Well Cell Culture Plate, 9.5 cm2, 34.8 mm Diam. Well, Sterile from Sigma-Aldrich
Biology Products: